Bristol-Myers Squibb Partnering 2009-2014

Date: March 1, 2014
Pages: 100
Price:
US$ 995.00
License [?]:
Publisher: CurrentPartnering
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), CD-ROM Mail Delivery, E-mail Delivery (Word)
ID: B0AC9CA080BEN
Leaflet:

Download PDF Leaflet

Bristol-Myers Squibb Partnering 2009-2014
This report provides all the information you require to better understand Bristol-Myers Squibb and its partnering interests and activities over the past seven years.

One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives.

The initial chapters of this report provide an orientation of bigpharma’s dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top 50 leading biopharma companies based on 2010 pharmaceutical revenues and their respective partnering activity. Chapter 3 provides an overview of the leading partnering and M&A 2009 to present date based on headline value.

Chapter 4 provides details on how to approach bigpharma companies with partnering opportunities whilst chapter 5 lists forthcoming partnering events and conferences where bigpharma companies will be present to discuss opportunities face to face.

The main body of the report is provided in chapter 6. A profile of the company provides everything required to assess the suitability of a company as a prospective partner. This includes a company overview, partnering interests, partnering activity according to deal type, industry sector, phase of development, and therapy area. The profile also includes in-depth contact information for individuals within the business development function.

The deals are listed by deal type, stage of development and therapy focus, allowing easy access to deals and alliances of interest. Every deal record links to an online, live version of the deal record at the Current Agreements deals and alliances database. Where available, deal records also include the contract document as disclosed at the SEC.

One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.

Understanding the flexibility of prospective partners’ negiotated deals terms provides critical insight into the negotiation process in termsof what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

In addition, contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each parties ability to derive value from the deal.

In summary, the report provides the user with the tools to make successful contact with the right partners effectively and efficiently.
EXECUTIVE SUMMARY

CHAPTER 1 – INTRODUCTION

CHAPTER 2 – BIOPHARMA TOP 50 AND DEALMAKING ACTIVITY

2.1 Biopharma partnering activity
2.2 Biopharma M&A activity

CHAPTER 3 – TOP BIGPHARMA DEALS BY VALUE

3.1 Bigpharma M&A
3.2 Bigpharma partnering

CHAPTER 4 – SUBMITTING OPPORTUNITIES TO PROSPECTIVE PARTNERS

4.1 How to submit an opportunity
4.2 Opportunity submission template
4.3 Sending emails
4.4 Face to face at partnering events
4.5 Online submission forms

CHAPTER 5 – FORTHCOMING PARTNERING EVENTS

CHAPTER 6 – COMPANY PROFILE

6.1 How to use company profiles
6.2 Field definitions
6.3 Company profile
  Partnering deals directory (2009-present) - by industry sector
  Bigpharma
  Pharmaceutical
  Biotech
  Diagnostic
  Drug delivery
  Government
  Medical device
  Consumer health
  Specialty pharma
  Generic pharma
  Agricultural
  Animal health
  Academic
  Non-profit
  Research tools
  Services
  Partnering deals directory (2009-present) - By deal type
  Asset purchase
  Co-Development
  Co-Market
  Co-Promotion
  Collaborative R&D
  Contract service
  Development
  Distribution
  Evaluation
  Joint venture
  Licensing
  Manufacture
  Marketing
  Promotion
  Research
  Royalty financing
  Supply
  Partnering deals directory (2009-present) – M&A
  Partnering deals directory (2009-present) - By stage of development
  Discovery
  Preclinical
  Phase I
  Phase II
  Phase III
  Regulatory
  Marketed
  Formulation
  Partnering deals directory (2009-present) - By therapy area
  Hospital care
  Cardiovascular
  Central nervous system
  Cosmetic
  Dental
  Dermatology
  Gastrointestinal
  Genetic disorders
  Genitourinary
  Hemotology
  Immunology
  Infectives
  Inflammatory
  Metabolic
  Musculoskeletal
  Oncology
  Ophthalmics
  Respiratory
  Sensory organ

ABOUT WILDWOOD VENTURES

Current Partnering
Current Agreements
Recent titles from CurrentPartnering
Order Form – Reports
Order Form – Partnering Agreements Company Profiles

TABLE OF FIGURES

Figure 1: Bigpharma partnering activity – top 50 by pharma sales
Figure 2: Bigpharma M&A activity – top 50 by pharma sales
Figure 3: Leading M&A deals involving bigpharma by value, 2009-2011
Figure 4: Leading partnering deals by value, 2009-2011
Figure 5: Typical partnering opportunity submission template
Figure 6: Company profile template and definitions used in report
Figure 7: Dealmaking frequency 2009-2011
Figure 8: Current partner companies (2009-present)
Figure 9: Partnering deals by type (2009-present)
Figure 10: Recent deals (2009-present) by industry sector
Figure 11: Recent deals (2009-present) by deal type
Figure 12: Recent deals (2009-present) by stage of development
Figure 13: Recent deals (2009-present) by therapy area

Ask Your Question

Bristol-Myers Squibb Partnering 2009-2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: